Equity Overview
Price & Market Data
Price: $9.10
Daily Change: +$1.69 / 18.57%
Daily Range: $7.45 - $9.77
Market Cap: $14,247,410
Daily Volume: 463,402
Performance Metrics
1 Week: -19.98%
1 Month: 140.5%
3 Months: -88.25%
6 Months: -89.11%
1 Year: -97.44%
YTD: -90.06%
Details
Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops cancer medicines based on cell cycle, transcriptional regulation, epigenetics, and mitosis control biology in the United States. Its lead product Plogosertib or plogo, a solid tumors and hematological malignancies, which is in Phase 1/2 clinical trial. The company was founded in 1996 and is headquartered in Kuala Lumpur, Malaysia.